2024 Conference Coverage


 

Long-Term (Up to 6 Years) Efficacy of Ofatumumab in People With Recently Diagnosed and Treatment-Naive Relapsing Multiple Sclerosis

0 views
May 3, 2024
Comments 0
Login to view comments. Click here to Login